Company Active LTD

Company profile

Wyoming Interactive Limited

Digital Transformation in Life Sciences | Wyoming Interactive

We specialise in helping Life Science companies drive digital transformation to improve commercial performance and customer engagement.

CRN
SC297378
Founded
2006
Age
20

Overview

Legal name
WYOMING INTERACTIVE LIMITED
Region
Scotland
Registered address
BONNINGTON BOND
2 ANDERSON PLACE
EDINBURGH
SCOTLAND
EH6 5NP
Insolvency history
No

Latest accounts

Financial period: 1 Jun 2023 to 31 May 2024

FILLETEDACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
37

Company events

Reference milestones and recent Companies House filing stream events.

5 events
21 Mar
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

28 Feb
2027

Accounts due

Accounts Due

Next accounts due date

07 Mar
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 May
2025

Accounts filed

Accounts

Last accounts made up date

20 Feb
2006

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2021
Funded years
2021, 2024
Age at first award
15 years

Projects

2024 Collaborative R&D

SHARPEN: SHARing data to accelerate Pharmaceutical manufacturing Efficiency across trusted Networks; A Framework for Risk Assessing the Value of Federated Learning to Improve the Fidelity of Models in Pharmaceutical Manufacturing

1 Aug 2024 to 31 Jan 2026

Awarded
£91,741
Total cost £131,059

The Pharmaceutical industry is really good at employing molecular-level chemistry models to help predict likely new cures for diseases. On the flip side it is bad (vs. other industries) at applying modelling to manufacturing to predict how and when to make products most effectively. This is for a number of reasons, one of which is the lack of good quality...

2021 Collaborative R&D

SmartPSC (Smart Pharma Supply Chain): Application of digital technologies to integrate pharma manufacturing supply chain and enhance efficiency, productivity, flexibility, resilience, and sustainability

1 Jun 2021 to 31 May 2023

Awarded
£164,227
Total cost £234,610

In order to meet National and International medicines demand, both small and large pharmaceutical companies need to use multiple suppliers. It takes significant effort to coordinate these separate companies and create an integrated plan that safely ensures patients get the medicines they need. Any changes to the plan take time and effort to manage and thi...

Product types

Collaborative R&D